References
Bruggers CS, Bleyl SB, Pysher T et al (2011) Clinicopathologic comparison of familial versus sporadic atypical teratoid/rhabdoid tumors (AT/RT) of the central nervous system. Pediatr Blood Cancer 56:1026–1031
Dykhuizen EC, Hargreaves DC, Miller EL et al (2013) BAF complexes facilitate decatenation of DNA by topoisomerase IIalpha. Nature 497:624–627
Eaton KW, Tooke LS, Wainwright LM et al (2011) Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors. Pediatr Blood Cancer 56:7–15
Frühwald MC, Hasselblatt M, Wirth S et al (2006) Non-linkage of familial rhabdoid tumors to SMARCB1 implies a second locus for the rhabdoid tumor predisposition syndrome. Pediatr Blood Cancer 47:273–278
Hasselblatt M, Gesk S, Oyen F et al (2011) Nonsense mutation and inactivation of SMARCA4 (BRG1) in an atypical teratoid/rhabdoid tumor showing retained SMARCB1 (INI1) expression. Am J Surg Pathol 35:933–935
Jackson EM, Sievert AJ, Gai X et al (2009) Genomic analysis using high-density single nucleotide polymorphism-based oligonucleotide arrays and multiplex ligation-dependent probe amplification provides a comprehensive analysis of INI1/SMARCB1 in malignant rhabdoid tumors. Clin Cancer Res 15:1923–1930
Jelinic P, Mueller JJ, Olvera N et al (2014) Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat Genet 46:424–426
Jones DT, Jäger N, Kool M et al (2012) Dissecting the genomic complexity underlying medulloblastoma. Nature 488:100–105
Judkins AR, Mauger J, Ht A et al (2004) Immunohistochemical analysis of hSNF5/INI1 in pediatric CNS neoplasms. Am J Surg Pathol 28:644–650
Kordes U, Gesk S, Frühwald MC et al (2010) Clinical and molecular features in patients with atypical teratoid rhabdoid tumor or malignant rhabdoid tumor. Genes Chromosomes Cancer 49:176–181
Pugh TJ, Weeraratne SD, Archer TC et al (2012) Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488:106–110
Ramos P, Karnezis AN, Craig DW et al (2014) Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat Genet 46:427–429
Robinson G, Parker M, Kranenburg TA et al (2012) Novel mutations target distinct subgroups of medulloblastoma. Nature 488:43–48
Schneppenheim R, Frühwald MC, Gesk S et al (2010) Germline nonsense mutation and somatic inactivation of SMARCA4/BRG1 in a family with rhabdoid tumor predisposition syndrome. Am J Hum Genet 86:279–284
Tsurusaki Y, Okamoto N, Ohashi H et al (2012) Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat Genet 44:376–378
Wilson BG, Roberts CW (2011) SWI/SNF nucleosome remodellers and cancer. Nat Rev Cancer 11:481–492
Witkowski L, Carrot-Zhang J, Albrecht S et al (2014) Germline and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type. Nat Genet 46:438–443
Witkowski L, Lalonde E, Zhang J et al (2013) Familial rhabdoid tumour ‘avant la lettre’–from pathology review to exome sequencing and back again. J Pathol 231:35–43
Acknowledgments
This work was supported by IZKF Münster (HA3/016/11); KinderKrebsInitiative Buchholz/Holm-Seppensen; and Fördergemeinschaft Kinderkrebszentrum Hamburg. EU-RHAB is supported by Deutsche Kinderkrebsstiftung; Gesellschaft für Kinderkrebsforschung Geltendorf; and “Horizont” Kinderkrebshilfe Weseke.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Hasselblatt, M., Nagel, I., Oyen, F. et al. SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis. Acta Neuropathol 128, 453–456 (2014). https://doi.org/10.1007/s00401-014-1323-x
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00401-014-1323-x